Welcome to our dedicated page for Xometry SEC filings (Ticker: XMTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xometry, Inc. filings document the public-company disclosures of an AI-native custom manufacturing marketplace with U.S. and international operations. Its 8-K reports commonly furnish quarterly and annual operating results, including marketplace growth drivers, gross profit trends, adjusted profitability measures, buyer and supplier network expansion, and enterprise engagement.
The filing record also includes material-event disclosures, material agreements, and capital-structure items involving Class A common stock. Proxy and annual meeting materials cover board composition, director elections, executive compensation, equity awards, advisory votes, auditor ratification, and related governance matters. These filings frame Xometry’s business around its marketplace, Thomasnet industrial sourcing platform, cloud-based services, real-time pricing, lead-time data, and custom manufacturing processes.
Xometry, Inc. (XMTR) reported that Chief Executive Officer and director Sanjeev Singh Sahni sold a total of 1,500 shares of Class A Common Stock on August 17, 2026 in multiple open-market or private transactions. The sales occurred at weighted-average prices between approximately $88 and $96 per share and were effected automatically under a Rule 10b5-1 trading plan adopted at least 90 days before the trading date.
Eventide Asset Management, LLC, together with Finny Kuruvilla, M.D., Ph.D. and Robin C. John, reports beneficial ownership of 2,151,845 shares of Xometry, Inc. Class A common stock, representing 4.0% of the class. Eventide holds sole voting and dispositive power over these shares, while Kuruvilla and John are reported as having shared voting and dispositive power over the same 2,151,845 shares. The group states that it now owns 5 percent or less of the class and, pursuant to Rule 13d-4, each filer expressly disclaims beneficial ownership of the securities. A joint filing agreement under Rule 13d-1(k)(1) confirms that this Schedule 13G/A is filed on behalf of all three reporting persons.
Xometry, Inc. director Fabio Rosati reported indirect sales of Class A Common Stock held by The Fabio Rosati 2022 Family Trust. On 2026-08-10 and 2026-08-11, the trust sold a total of 10,000 shares in four open-market transactions at weighted average prices, with per-transaction ranges from $89.29 to $93.49 per share.
Xometry, Inc. Chief Financial Officer Miln James reported selling 1,500 shares of Class A Common Stock on August 6, 2026. The sales occurred in multiple transactions under an automatic Rule 10b5-1 trading plan adopted at least 90 days earlier, at weighted average prices ranging from $86.825 to $90.28 per share.
James Miln filed a notice of intent to sell 1,500 shares of XMTR Class A Common Stock through UBS Financial Services on or after August 6, 2026. The planned sale has an aggregate market value of $135,420.00. The shares relate to a stock award dated March 1, 2025.
The filing also lists prior sales of XMTR Class A Common Stock over the past three months, each reported with the number of shares and total sale price.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 3,974,447.14 shares of Xometry Inc. Class A common stock, representing 7.4% of the class as of June 30, 2026. FMR LLC reports sole dispositive power over these shares and sole voting power over 3,973,866 shares.
Abigail P. Johnson is also reported as a beneficial owner with sole dispositive power over 3,974,447.14 shares, corresponding to the same 7.4% stake, but no sole or shared voting power. One or more other persons may receive dividends or sale proceeds from these securities, but no such person holds more than five percent of the outstanding Class A common stock.
Xometry, Inc., an AI-native online manufacturing marketplace, reported Q2 2026 revenue of $229,280 (in thousands), up from $162,547 (in thousands) a year earlier, driven mainly by marketplace sales of $215,369 (in thousands). Gross profit increased to $87,153 (in thousands), while operating expenses rose to $92,698 (in thousands), narrowing the loss from operations to $5,545 (in thousands) from $10,290 (in thousands). Net loss attributable to common stockholders improved to $5,313 (in thousands), or $0.10 per share, versus $26,434 (in thousands), or $0.52 per share, in Q2 2025. For the first six months of 2026, revenue reached $434,419 (in thousands) with net loss of $10,580 (in thousands).
Segment revenue in Q2 2026 was $194,749 (in thousands) from the U.S. and $34,531 (in thousands) from International operations. Adjusted EBITDA turned meaningfully higher, reaching $14,143 (in thousands) in Q2 2026 and $24,629 (in thousands) for the first half, compared with $3,926 (in thousands) and $4,004 (in thousands), respectively, in 2025. Operating cash flow for the first half of 2026 was positive $17,542 (in thousands), versus a use of $4,118 (in thousands) in the prior-year period.
As of June 30, 2026, Xometry held $21,753 (in thousands) in cash and cash equivalents and $494,916 (in thousands) in marketable securities, with total assets of $1,057,809 (in thousands) and stockholders’ equity of $595,023 (in thousands). During the first half, the company raised approximately $248,400 (in thousands) net from a common stock offering and $50,000 (in thousands) from a Siemens-related stock purchase. Xometry has $335,805 (in thousands) of convertible senior notes outstanding; sale price triggers for both the 2027 and 2030 notes were met, allowing holders to convert during the quarter following June 30, 2026.
Xometry reported record second-quarter 2026 results, with revenue of $229 million, up 41% year-over-year, driven mainly by its AI-native marketplace. Marketplace revenue reached $215 million, up 45%, while gross profit grew 34% to $87.2 million.
The company still posted a GAAP net loss attributable to common stockholders of $5.3 million, but delivered strong profitability on a non-GAAP basis: Adjusted EBITDA was $14.1 million, improving by $10.2 million year-over-year, with margins up 380 points to 6.2%. Non-GAAP net income was $9.9 million versus $1.1 million a year earlier.
Marketplace scale continued to expand, with Active Buyers rising 20% to 89,557 and large accounts (last twelve-month spend ≥ $50,000) up 23% to 2,039. Liquidity strengthened meaningfully: cash, cash equivalents and marketable securities totaled $517 million as of June 30, 2026, boosted by a $248 million equity follow-on and a $50 million private placement with Siemens. Xometry raised its full-year 2026 revenue growth outlook to 33–34% and now expects full-year Adjusted EBITDA of $60–$62 million.